The global biologics market is projected to reach USD 567.96 Billion in 2028 at a steady revenue CAGR of 8.4% over the forecast period, according to latest analysis by Emergen Research. Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others
The report contains unbiased industry expert opinions on the current market scenario, past market performance, production & consumption rates, demand & supply ratio, and revenue generation forecasts over the estimated period. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the Biologics market players.
Get a sample of the report : https://www.emergenresearch.com/request-sample/61
The latest report is the most recent study that offers 360° coverage of the Biologics industry that has been facing the brunt of the adverse economic impact of the COVID-19 outbreak since the beginning of this year. The global health crisis has affected nearly every aspect of the business vertical and led to massive disruptions to the global Biologics market demand and supply chains. Researchers draw predictions for the market scenario in the post-COVID era. The report, additionally, assesses the present market situation and estimates its future outcomes, keeping in mind the impact of the pandemic on the global economic landscape.
Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others.
Among the application segments, the cancer segment accounted for largest revenue share in 2020. Biologics assists the immune system in quickly recognizing cancer cells in the human body, as well as attacking the malignant cells, switching on/off the signals from cancerous cells and aiding in dodging the immune system cells.
The market in Asia Pacific is expected to register fastest revenue CAGR over forecast period due to improving healthcare infrastructure, rising investments in biologics development, and better reimbursement scenario in some countries in the region.
Some major companies operating in the global market include Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., Eli Lilly & Company, F Hoffman La Roche, Addgene, Novartis AG, and GlaxoSmithKline.
Emergence of several startups such as ILYA Pharma, Elasmogen, Cygnal Therapeutics, TiumBio, and Entos Pharmaceuticals is also contributing significantly to market growth.
Additionally, the rapidly increasing burden of chronic diseases globally is fueling market growth. According to statics released by World Health Organization (WHO), the burden of chronic diseases had been estimated to increase by 57.0% from 2001 to 2020. Developing countries are expected to be highly impacted, thereby contributing to 60.0% of the global burden of chronic diseases.
Request a discount on the report : https://www.emergenresearch.com/request-discount/61
TOC of the global Biologics market report:
Chapter 1, describes the Biologics Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.
Chapter 2, analyzes the key manufacturers of Biologics , along with the sales, revenue, and price of Biologics , in the forecast period.
Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.
Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of Biologics , for each region, from 2020 to 2027.
Chapters 5, 6, 7, 8 and 9, analyze the Biologics market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued
Key Points of Biologics Market:
Extensive coverage of the analysis of the Biologics market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Biologics market
Complete data about the key manufacturers and vendors in the Biologics market
Read More: https://www.emergenresearch.com/industry-report/biologics-market
Related reports:
|
Neurostimulation Devices Market |
|
Mobile Robot Market |
|
Free Space Optics (FSO) CommunicationTechnologyMarket |
|
Anti-Aging Devices Market |
|
Thermoelectric Materials Market |
|
Airborne LiDAR Market |
|
Medical Wearables Market |
|
Medical Wearable Market |
|
Membrane Bioreactor Market |
|
Peristaltic Pumps Market |
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
